JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P 500 Value ETF
IVE
|
+$2.05B |
| 2 |
iShares S&P 500 Growth ETF
IVW
|
+$1.92B |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.13B |
| 4 |
iShares Russell 1000 Value ETF
IWD
|
+$1.1B |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$1.06B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.24B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.12B |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$989M |
| 4 |
Microsoft
MSFT
|
+$973M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$931M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.54% |
| 2 | Technology | 14.97% |
| 3 | Healthcare | 10.91% |
| 4 | Financials | 10.87% |
| 5 | Consumer Discretionary | 8.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4676
Schwab Fundamental Emerging Markets Large Company Index ETF
FNDE
$10.3B
| $30K | ﹤0.01% |
1,437
| – | – |
2018 Q2
7 quarters
|
|
|
SOHU
4677
Sohu.com
SOHU
$325M
| $30K | ﹤0.01% |
4,741
-220,952
| -98% | -$2.2M |
2015 Q4
17 quarters
|
|
4678
Talphera
TLPH
$58.7M
| $30K | ﹤0.01% |
1,252
-32
| -2% | -$977 |
2019 Q2
3 quarters
|
|
4679
United States 12 Month Oil Fund,
USL
$49M
| $30K | ﹤0.01% |
+2,475
| New | +$46.4K |
2020 Q1
0 quarters
|
|
|
NTP
4680
DELISTED
Nam Tai Property Inc.
NTP
| $30K | ﹤0.01% |
5,511
+3,859
| +234% | +$28.5K |
2019 Q4
1 quarter
|
|
|
AC
4681
DELISTED
Associated Capital Group
AC
| $29K | ﹤0.01% |
936
+86
| +10% | +$3.44K |
2015 Q4
17 quarters
|
|
|
CLPR
4682
Clipper Realty
CLPR
$50.7M
| $29K | ﹤0.01% |
5,559
+827
| +17% | +$8.19K |
2017 Q4
9 quarters
|
|
4683
CorMedix
CRMD
$560M
| $29K | ﹤0.01% |
8,165
-18,711
| -70% | -$106K |
2019 Q2
3 quarters
|
|
4684
Fastly Inc
FSLY
$4.11B
| $29K | ﹤0.01% |
1,527
-13,596
| -90% | -$281K |
2019 Q4
1 quarter
|
|
4685
Avita Medical
RCEL
$393M
| $29K | ﹤0.01% |
+924
| New | +$38.3K |
2020 Q1
0 quarters
|
|
|
TMX
4686
DELISTED
Terminix Global Holdings, Inc.
TMX
| $29K | ﹤0.01% |
1,091
-1,525,455
| -100% | -$52M |
2014 Q3
22 quarters
|
|
|
CEL
4687
DELISTED
Cellcom Israel, Ltd.
CEL
| $29K | ﹤0.01% |
10,011
-39,088
| -80% | -$126K |
2019 Q4
1 quarter
|
|
4688
Carvana
CVNA
$45.9B
| $28K | ﹤0.01% |
2,525
+305
| +14% | +$4.72K |
2017 Q2
11 quarters
|
|
4689
ORIX
IX
$38.6B
| $28K | ﹤0.01% |
2,390
+865
| +57% | +$13.7K |
2013 Q2
27 quarters
|
|
4690
Invesco Biotechnology & Genome ETF
PBE
$415M
| $28K | ﹤0.01% |
+612
| New | +$31.9K |
2020 Q1
0 quarters
|
|
4691
ProShares Ultra Technology
ROM
$1.44B
| $28K | ﹤0.01% |
2,040
-1,664
| -45% | -$32.5K |
2018 Q4
5 quarters
|
|
|
WTPI
4692
WisdomTree Equity Premium Income Fund
WTPI
$543M
| $28K | ﹤0.01% |
+1,250
| New | +$33.4K |
2020 Q1
0 quarters
|
|
4693
Comstock Resources
CRK
$3.75B
| $27K | ﹤0.01% |
4,988
+42
| +0.8% | +$250 |
2019 Q1
4 quarters
|
|
4694
Invesco KBW High Dividend Yield Financial ETF
KBWD
$359M
| $27K | ﹤0.01% |
+2,509
| New | +$48.8K |
2020 Q1
0 quarters
|
|
4695
Matinas BioPharma
MTNB
$2.59M
| $27K | ﹤0.01% |
60
| – | – |
2017 Q2
11 quarters
|
|
|
NOAH
4696
Noah Holdings
NOAH
$535M
| $27K | ﹤0.01% |
1,034
-735
| -42% | -$23.2K |
2016 Q3
14 quarters
|
|
4697
USA Compression Partners
USAC
$3.68B
| $27K | ﹤0.01% |
4,638
-18,190
| -80% | -$242K |
2015 Q4
17 quarters
|
|
|
EVA
4698
DELISTED
Enviva Inc.
EVA
| $27K | ﹤0.01% |
1,000
-1,940
| -66% | -$67.5K |
2018 Q2
7 quarters
|
|
|
GRTX
4699
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
| $27K | ﹤0.01% |
2,828
+609
| +27% | +$7.85K |
2019 Q4
1 quarter
|
|
|
HARP
4700
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $27K | ﹤0.01% |
235
-3
| -1% | -$422 |
2019 Q1
4 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2020 Portfolio in Review
As of Q1 2020, JP Morgan Chase held 6,012 positions worth $426B, down 21% from $536B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase deployed $14B of net new capital in Q1 2020, opening 362 new positions and adding to 2,382 existing holdings. Its largest new stake was NextEra Energy, Inc. 5.279% Corporate Units: 1,245,017 shares worth $54.9M.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was JPMorgan BetaBuilders Japan ETF, an estimated $1.24B trimmed.
- JP Morgan Chase's largest Q1 2020 buy was NextEra Energy, Inc. 5.279% Corporate Units: 1,245,017 shares worth $54.9M.
- JP Morgan Chase added most to iShares S&P 500 Value ETF in Q1 2020, an estimated $2.05B increase.
- JP Morgan Chase's biggest Q1 2020 reduction was JPMorgan BetaBuilders Japan ETF, cutting an estimated $1.24B.
- JP Morgan Chase fully exited Liberty Property Trust in Q1 2020, selling an estimated $264M.
- JP Morgan Chase's ten largest holdings make up 18% of its $426B portfolio in Q1 2020.
- JP Morgan Chase opened 362 new positions and closed 692 in Q1 2020.
- JP Morgan Chase's portfolio value fell 21% quarter-over-quarter to $426B.
Based on JP Morgan Chase's 13F filing for Q1 2020, filed 12 May 2020.